The Investment Whisperer
  • Business
  • Politics
  • Investing
  • World
  • Business
  • Politics
  • Investing
  • World

The Investment Whisperer

Investing

RAD Doses 1st Patient in Therapeutic Trial of 177Lu-RAD202

by admin June 4, 2025
June 4, 2025
RAD Doses 1st Patient in Therapeutic Trial of 177Lu-RAD202

Radiopharm Theranostics (RAD:AU) has announced RAD Doses 1st Patient in Therapeutic Trial of 177Lu-RAD202

Download the PDF here.

This post appeared first on investingnews.com

0
FacebookTwitterGoogle +Pinterest
previous post
5 Biggest Blockchain ETFs in 2025
next post
Adam Rozencwajg: Gold Stock Gains, Silver and Uranium Prices — Plus PGMs Bull Case

Related Posts

Cybersecurity Stocks: 10 Biggest Companies in 2025

January 12, 2025

Acquisition of Bengal Mining – Highly Prospective Lithium...

April 24, 2024

Nickel Price Forecast: Top Trends That Will Impact...

January 6, 2024

Sankamap Provides Update on Late Filing of Financial...

January 14, 2026

Drilling in Progress at Odienne Project, Côte d’Ivoire

May 27, 2024

Galan Builds Inventory with 1,000t LCE, Advances HMW...

May 16, 2024

Operational and Financial Update

April 10, 2024

CLEO Appoints CRO to Manage U.S. Ovarian Cancer...

April 12, 2024

Spartan Resources

December 12, 2023

Constellation to Revive Three Mile Island, Sell Power...

September 24, 2024

    Stay updated with the latest news, exclusive offers, and special promotions. Sign up now and be the first to know! As a member, you'll receive curated content, insider tips, and invitations to exclusive events. Don't miss out on being part of something special.


    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    Categories

    • Business (1,594)
    • Investing (5,166)
    • Politics (6,807)
    • World (4,762)
    • About us
    • Contact us
    • Privacy Policy
    • Terms & Conditions

    Disclaimer: TheInvestmentWhisperer.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

    Copyright © 2024 TheInvestmentWhisperer.com | All Rights Reserved